These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33431416)

  • 1. Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.
    Pfaller MA; Messer SA; Deshpande LM; Rhomberg PR; Utt EA; Castanheira M
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.
    Gamal A; Long L; Herrada J; Aram J; McCormick TS; Ghannoum MA
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0054921. PubMed ID: 34228541
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution.
    Mesquida A; Alcoceba E; Padilla E; Ramírez A; Merino P; González-Romo F; De Carolis E; Sanguinetti M; Mantecón-Vallejo MLÁ; Muñoz-Algarra M; Durán-Valle T; Pérez-Ayala A; Gómez-García-de-la-Pedrosa E; Del Carmen Martínez-Jiménez M; Sánchez-Castellano MÁ; Quiles-Melero I; Cuétara MS; Sánchez-García A; Muñoz P; Escribano P; Guinea J;
    Mycoses; 2024 Mar; 67(3):e13706. PubMed ID: 38438313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
    Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.
    Arendrup MC; Prakash A; Meletiadis J; Sharma C; Chowdhary A
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416539
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
    Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
    Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
    Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation of the Direct Contribution of Candida auris
    Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
    Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
    Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
    J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.